@article{21da34f6f5b0421286f89d25ca17d854,
title = "The Toxicology Investigators Consortium 2020 Annual Report",
abstract = "The Toxicology Investigators Consortium (ToxIC) Registry was established by the American College of Medical Toxicology in 2010. The registry collects data from participating sites with the agreement that all bedside and telehealth medical toxicology consultation will be entered. This eleventh annual report summarizes the Registry{\textquoteright}s 2020 data and activity with its additional 6668 cases. Cases were identified for inclusion in this report by a query of the ToxIC database for any case entered from January 1 to December 31, 2020. Detailed data was collected from these cases and aggregated to provide information which included demographics, reason for medical toxicology evaluation, agent and agent class, clinical signs and symptoms, treatments and antidotes administered, mortality, and whether life support was withdrawn. Gender distribution included 50.6% cases in females, 48.4% in males, and 1.0% identifying as transgender. Non-opioid analgesics were the most commonly reported agent class, followed by opioid and antidepressant classes. Acetaminophen was once again the most common agent reported. There were 80 fatalities, comprising 1.2% of all registry cases. Major trends in demographics and exposure characteristics remained similar to past years{\textquoteright} reports. Sub-analyses were conducted to describe race and ethnicity demographics and exposures in the registry, telemedicine encounters, and cases related to the COVID-19 pandemic.",
keywords = "Epidemiology, Medical Toxicology, Overdose, Poisoning, Surveillance",
author = "{On behalf of the Toxicology Investigators Consortium Study Group} and Spyres, {Meghan B.} and Kim Aldy and Farrugia, {Lynn A.} and Kang, {A. Min} and Love, {Jennifer S.} and Campleman, {Sharan L.} and Shao Li and Alexandra Amaducci and Evan Schwarz and Wax, {Paul M.} and Jeffery Brent and J. Acciani and Akpunonu, {P. D.} and S. Aks and Algren, {D. A.} and S. Atti and R. Avera and Baum, {R. A.} and Beauchamp, {G. A.} and D. Bentur and M. Beuhler and Boyle, {K. L.} and M. Brenner and R. Bruccoleri and M. Burns and B. Button and Calello, {D. P.} and J. Canning and Cannon, {R. D.} and D. Cao and Carey, {J. L.} and J. Carpenter and J. Castaneda and R. Castelli and A. Cates and V. Ceretto and R. Chen and Christian, {M. R.} and K. Conner and Cook, {M. D.} and M. Correia and P. Dargan and {De Olano}, J. and T. DeGelorm and J. Devgun and W. Dribben and Hendrickson, {R. G.} and Hughes, {A. R.} and Kusin, {S. G.} and Noble, {M. J.}",
note = "Funding Information: The Toxicology Investigators Consortium received funding from the US National Institute of Drug Abuse (1RO1DA037317- 02) and the American Academy of Addiction Psychiatry (1H79TI083343) and has data-sharing contracts with the U.S. Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and BTG International, Inc. (North America). Funding Information: In 2020 ToxIC was supported by the NIH, FDA, CDC, and BTG International. These collaborations have been enriching for ToxIC but more importantly have provided unique networking opportunities for ToxIC investigators. Publisher Copyright: {\textcopyright} 2021, American College of Medical Toxicology.",
year = "2021",
month = oct,
doi = "10.1007/s13181-021-00854-3",
language = "English (US)",
volume = "17",
pages = "333--362",
journal = "Journal of Medical Toxicology",
issn = "1556-9039",
publisher = "Springer New York",
number = "4",
}